Browsing by Author Kiat Ruxrungtham

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 10 to 17 of 17 < previous 
Issue DateTitleAuthor(s)
15-Jun-2013Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudineMichele W. Tang; Soo Yon Rhee; Silvia Bertagnolio; Nathan Ford; Susan Holmes; Kim C. Sigaloff; Raph L. Hamers; Tobias F.Rinke De Wit; Herve J. Fleury; Phyllis J. Kanki; Kiat Ruxrungtham; Claudia A. Hawkins; Carole L. Wallis; Wendy Stevens; Gert U. Van Zyl; Weerawat Manosuthi; Mina C. Hosseinipour; Nicole Ngo-Giang-Huong; Laurent Belec; Martine Peeters; Avelin Aghokeng; Torsak Bunupuradah; Sherri Burda; Patricia Cane; Giulia Cappelli; Charlotte Charpentier; Anoumou Y. Dagnra; Alaka K. Deshpande; Ziad El-Katib; Susan H. Eshleman; Joseph Fokam; Jean Chrysostome Gody; David Katzenstein; Donato D. Koyalta; Johnstone J. Kumwenda; Marc Lallemant; Lutgarde Lynen; Vincent C. Marconi; Nicolas A. Margot; Sandrine Moussa; Thumbi Ndung'U; Phillipe N. Nyambi; Catherine Orrell; Jonathan M. Schapiro; Rob Schuurman; Sunee Sirivichayakul; Davey Smith; Maria Zolfo; Michael R. Jordan; Robert W. Shafer
1-Jan-2022Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patientsNoppaket Singkham; Anchalee Avihingsanon; Richard C. Brundage; Angela K. Birnbaum; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Torsak Bunupuradah; Sasisopin Kiertiburanakul; Ploenchan Chetchotisakd; Baralee Punyawudho
1-Nov-2017Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patientsKanokrat Rungtivasuwan; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Siwaporn Mitruk; David M. Burger; Kiat Ruxrungtham; Chonlaphat Sukasem; Baralee Punyawudho
1-Mar-2017Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patientsBaralee Punyawudho; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Anchalee Avihingsanon
1-Nov-2015Population pharmacokinetics of tenofovir in HIV/HBV co-infected patientsBaralee Punyawudho; Narukjaporn Thammajaruk; Parawee Thongpeang; Gail Matthews; Sharon R. Lewin; David Burger; Kiat Ruxrungtham; Anchalee Avihingsanon
1-Jul-2017Safety, pharmacokinetics, and antiviral activity of a novel HIV antiviral, ABX464, in treatment-naive HIV-infected subjects in a phase 2 randomized, controlled studyJean Marc Steens; Didier Scherrer; Paul Gineste; P. Noel Barrett; Supparatpino Khuanchai; Ratanasuwan Winai; Kiat Ruxrungtham; Jamal Tazi; Robert Murphy; Hartmut Ehrlich
1-Jan-2017Strategies to improve the immunogenicity of prM+E dengue virus type-2 DNA vaccineChutitorn Ketloy; Poonsook Keelapang; Eakachai Prompetchara; Amporn Suphatrakul; Chunya Puttikhunt; Watchara Kasinrerk; Eiji Konishi; Nopporn Sittisombut; Kiat Ruxrungtham
1-Dec-2016Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patientsBaralee Punyawudho; Noppaket Singkham; Narukjaporn Thammajaruk; Theera Dalodom; Stephen J. Kerr; David M. Burger; Kiat Ruxrungtham